Background. Application of icodextrin-based peritoneal dialysis fluid (PDF) provides a potential benefit in patients with diabetes and end-stage renal failure treated with continuous ambulatory peritoneal dialysis (CAPD) because of better ultrafiltration capacity and avoidance of direct glucose exposure. We examined the effect of glucose and icodextrin-based PDF on histological alterations of peritoneal membranes. Methods. Thirty-two male Wistar rats were divided into four groups: control Wistar rats with non-treated (n = 8), streptozotocin (STZ)-induced diabetic rats with 5/6 kidney ablation (n = 8), STZ-induced diabetic rats with 5/6 kidney ablation injected with a standard lactate-buffered 4.25% glucose-based PDF (Dianeal R ; n = 8) and STZ-induced diabetic rats with 5/6 kidney ablation injected with 7.5% icodextrin-based PDF (Extraneal R ; n = 8). Intraperitoneal injection was performed once daily with an instillation volume of 20 ml per injection during 8 weeks. Results. Chronic high-glucose-based PDF exposure resulted in increased vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression, accumulation of advanced glycation end-products (AGEs), and up-regulation of the receptor for AGE (RAGE), which were ameliorated in the icodextrin-based PDF group. The peritoneal damages, such as neoangiogenesis and submesothelial fibrosis, were significantly reduced in icodextrin-based PDF compared to high-glucose-based PDF.
Introduction
Diabetic nephropathy is the leading cause of end-stage renal diseases worldwide. Although survival is substantially equivalent in patients who have diabetes and are on haemodialysis or peritoneal dialysis (PD), only a small proportion of patients with diabetes receive PD treatment. In Japan, only approximately 2.5% of dialysis patients with diabetes in 2005 were receiving peritoneal dialysis [1] , and similarly small percentage (5%) was recorded in the United States in the same year [2] . There are various reasons for a small number of patients with diabetes receiving PD. First, the selection of treatment is substantially influenced by cultural, logistic and reimbursement policies rather than by medical considerations, and wide differences are noted among various countries. Second, the disadvantage of over-hydration and glucose adsorption has not been resolved in diabetic PD patients. In general, volume overload and congestive heart disease are frequently observed in patients with diabetic nephropathy. To achieve more efficient peritoneal ultrafiltration, the traditional hypertonic glucosebased peritoneal dialysis fluid (PDF) would be used, and thus the greater glucose exposure may lead to higher peritoneal permeability, loss of ultrafiltration and poorer glycaemic control. Peritoneal damage, i.e. membrane thickening and vascular alterations, occurs in response to a variety of injuries like bioincompatible dialysis solutions, peritonitis, uraemia, diabetes and chronic inflammation. The precise pathogenesis of peritoneal damage due to bioincompatible PDF is not entirely clear. It is widely assumed that peritoneal tissue is exposed to numerous harmful conditions and bioactive chemicals in bioincompatible PDF 14 8 - 8 such as low pH, lactate, glucose, glucose degradation products (GDPs), hyperosmolality and advanced glycation end-products (AGEs) during PD treatment. In particular, increasing evidence is accumulating, which implicates the AGE-RAGE (receptor for AGE) interaction as an important factor in peritoneal membrane damage [3, 4] .
The iso-osmolar glucose-polymer-based peritoneal solution icodextrin is characterized by an improved and sustained ultrafiltration profile [5] . In addition, icodextrin was shown to result in less in vitro AGE formation and production of GDP than high-glucose-based PDFs [6, 7] . In a variety of in vitro, ex vivo and in vivo assays, icodextrin also appears to be potentially less damaging to the peritoneum and to peritoneal defence compared to the hyperosmolar glucose solution [8, 9] . Further, several ex vivo studies have demonstrated improvements in both peritoneal and mesothelial cell function in patients using icodextrin-based PDF, while using conventional PDF for all other exchanges [10, 11] . On the basis of these findings, the use of icodextrin may prevent or delay histological alterations and sustain the peritoneal function during long-term diabetic PD treatment by reducing the potential avenues of glucose-induced toxicity, and GDP-mediated AGE formation.
The aim of the present study was to investigate the chronic effect of icodextrin-based PDF on the structure of the peritoneal membrane in an STZ-induced diabetic and uraemic rat model, compared with high-glucose-based PDF.
Materials and methods

Laboratory animals
The study was performed in Wistar male rats 6-weeks of age (n = 32), which received care in accordance with the national guidelines for animal protection. Animals for the experiments were divided into four groups, as follows: Group C1 was control rats with non-treated, Group C2 was streptozotocin (STZ)-induced diabetic rats with 5/6 kidney ablation without injection, Group G was STZ-induced diabetic rats with 5/6 kidney ablation injected with standard 4.25% glucose-based PDF, Group I was STZ-induced diabetic rats with 5/6 kidney ablation injected with 7.5% icodextrin-based PDF.
Uraemia was induced by the progressive resection of 5/6 of renal tissue during two operations carried out under ether anaesthesia. Diabetes was induced by a single intravenous injection of STZ (55 mg/kg body weight) dissolved in a citrate buffer, pH 4.6 after renal resection was done. Three days after STZ administration, the animals were weighed and tail vein blood glucose was determined by Glucocard. Insulin (Humacart N R ; Eli Lilly, Indianapolis, IN, USA) (1-5 units/day, subcutaneously) was initiated 5 days after administration of STZ after confirming that all of the animals revealed blood glucose levels higher than 400 mg/dl. The daily glucose measurement and insulin administration were performed to maintain blood glucose between 400 and 500 mg/dl and to avoid ketosis before PDF injection. Experiments were carried out 7 days after the injection of STZ. The weight of the rats was recorded weekly. They received once daily intraperitoneal injections of 20 ml of 4.25% glucose-based PDF (Dianeal R ; n = 8) and a 7.5% icodextrin-based PDF (Extraneal R ; n = 8). In order to evaluate the glucose concentrations in dialysis fluid, the dialysate samples were taken at 0, 4 and 8 h after 4.25% glucose-based or 7.5% icodextrin-based PDF had been injected. The dialysate glucose concentrations were analysed using the hexokinase method.
After 8 weeks, we withdraw the blood samples and sacrificed them to obtain the interior abdominal peritoneal wall for histological examinations.
Peritoneal tissue samples were fixed in 10% neutral buffered formalin and embedded in paraffin. Sections of 4 μm were prepared for histology and immunohistochemistry.
Histological analysis
Formalin-fixed, paraffin-embedded sections (4 μm) were stained with Masson's trichrome for light microscopic observation. The thickness of the submesothelial collagenous zone above the abdominal muscle layer in cross-sections of the abdominal wall was defined as peritoneal thickness as described previously [12, 13] . Measurement of the peritoneal thickness was performed by image analysis at ×400 original magnification using the Micro Analyzer software ver.1.1 (Nippon Poldigital Co., Japan). In each image, peritoneal thickness was measured at 10 different points. Peritoneal fibrosis was defined as a submesothelial compact zone thickness exceeding 8 μm based on the highest value recorded for control subjects not receiving PD fluid injections.
Immunohistochemistry
Immunoperoxidase staining of peritoneal tissue was performed using 4 μm formalin-fixed, paraffin-embedded sections, as described previously [12, 13] . The following antibodies were used as primary antibodies: Thereafter, the sections were washed with PBS and incubated with biotinylated secondary antibodies for 40 min. The following biotinylated antibodies were used as secondary antibodies: (1) donkey anti-rabbit IgG (1:100 dilution; Jackson Immuno Research Labs, Inc., West Grove, PA, USA) for vWF, FGF-2 and RAGE; (2) donkey anti-mouse IgG (1:100 dilution; Jackson Immuno Research Labs., Inc., West Grove, PA, USA) for fibronectin, VEGF and AGE. Diaminobenzidine was used as a chromogen. All slides were counterstained with haematoxylin. Normal mouse IgG and rabbit IgG were used as negative controls. The positively stained cells/submesothelial zone area ratio or the number of blood vessels was determined by observing more than 10 fields at ×400 original magnification in each section. In addition to this morphometric analysis, we measured the submesothelial area in each image using the Micro Analyzer software and expressed positively stained vessels and cells as the number per submesothelial area (mm 2 ) in order to exclude the influence of the submesothelial thickness on each parameter.
Statistical analysis
The results were expressed as mean ± SEM. Statistical analysis was performed by SPSS for windows release 11.0 (Chicago, Illinois), using analysis of variance (ANOVA) and, where appropriate, the Tukey test was used as a multiple comparison t test. The significance level was set at P < 0.05.
Results
Metabolic and biochemical data
The metabolic and biochemical data of the experimental rats are summarized in Table 1 . After subtotal nephrectomy and induction of diabetes, the rats revealed decreased gain of body weight, increased serum urea and creatinine. At 4 and 8 weeks, the body weight of the PDF-injected rats was significantly lower than that of rats without PDF-injection. There was no significant difference in blood glucose levels between STZ-induced diabetic rats. The serum urea and creatinine levels were 1-to 2-fold higher in subtotal nephrectomized rats as compared with non-nephrectomized rats at any time point. There were no significant differences in body weight, plasma glucose, serum urea and creatinine between 4.25% glucose and 7.5% icodextrin groups during the 8 weeks. The dialysate glucose concentrations increased C1, control; C2, diabetic rats with 5/6 kidney ablation; G, diabetic rats with 5/6 kidney ablation injected 4.25% glucose-based peritoneal dialysis fluid (PDF); I, diabetic rats with 5/6 kidney ablation injected 7.5% icodextrin-based PDF. There were no significant differences in body weight, plasma glucose, serum urea and creatinine between G and I groups. All values are mean ± s.e. n = 8 in each group. a P < 0.05 versus C1 group. b P < 0.05 versus C2 group. Dialysate glucose concentrations at baseline, 4-h and 8-h dwell after injection of 4.25% glucose or 7.5% icodextrin-based peritoneal dialysis fluid (PDF). Glucose concentrations in dialysate of streptozotocin induced-diabetic rats with 5/6 ablation was measured during the 8-h dwell. Symbols are ( ) 4.25% glucose-based PDF injected group (n = 8); (•) 7.5% icodextrin-based PDF injected group (n = 8). † P < 0.01 versus 4.25% glucose-based PDF injected group, # P < 0.01 compared at 0 h in 7.5% icodextrin-based PDF injected group. Data are mean ± s.e. during the dwell in the icodextrin-based PDF injected group but progressively decreased in the 4.25% glucose-based PDF injected group (Figure 1) . The glucose concentrations in dialysis fluid were significantly lower with 7.5% icodextrin-based PDF than with 4.25% glucose-based PDF at 0 h (2.0 ± 0.2 versus 4005.6 ± 32.0 mg/dl; P < 0.01), 4 h (279.9 ± 41.8 versus 918.0 ± 162.3 mg/dl; P < 0.01) and 8 h (306.9 ± 58.1 versus 520.2 ± 57.8 mg/dl; P < 0.01). In the 7.5% icodextrin-based PDF injected group, the glucose concentrations in the dialysate significantly increased during the first 4 h of the dwell (P < 0.01, Figure 1 ), and then slightly after 8 h without statistical differences.
Histology and morphometric analysis
Morphologic changes of the anterior abdominal wall were analysed by Masson's trichrome staining. In the normal rats, a monolayer of mesothelial cells was observed covering the surface without any thickening of the peritoneum (Figure 2a ). The thickness of the peritoneum in STZinduced diabetic rats with 5/6 kidney ablation was significantly increased as compared to control rats (Figure 2b ). The appearance of the peritoneum of rats receiving intraperitoneal injection of 4.25% glucose-based PDF solution resulted in the most marked thickening of the submesothelial compact zone and increased cellularity (Figure 2c ). The thickness of the submesothelial compact zone induced by 7.5% icodextrin-based PDF was significantly lower than that by 4.25% glucose-based PDF (Figure 2d ).
Immunohistochemical analysis of the peritoneum
Morphometric analysis of immunohistochemical findings in four groups was summarized in Table 2 . We examined the expression of endothelial cell marker vWF in the peritoneum. The number of vWF-positive vessels in the peritoneum was markedly increased by 4.25% glucose-based PDF injection compared with two control groups and 7.5% icodextrin-based PDF injected group (Figure 3a-d) . There was no significant difference in vWF expression and vascular density between two control groups and 7.5% icodextrinbased PDF injected group (Figure 3a, b and d) . Similarly, VEGF expression was increased in 4.25% glucose-based PDF exposed peritonea, most distinctly in the mesothelial Fig. 2 . Histological appearance of peritoneum. Representative light microscopic appearance of peritoneal tissues (Masson's trichrome staining, ×400 original magnification) for the (a) control group, (b) diabetic rats with 5/6 kidney ablation, (c) diabetic rats with 5/6 kidney ablation injected standard 4.25% glucose-based peritoneal dialysis fluid (PDF) for 8 weeks (n = 8), (d) diabetic rats with 5/6 kidney ablation injected 7.5% icodextrin-based PDF for 8 weeks (n = 8). → The thickness of submesothelial collagenous zone in both 4.25% glucose and 7.5% icodextrin PDF-injected rats was significantly increased over that of non-injected rats. In addition, peritoneal thickness in the 7.5% icodextrin-based PDF-injected rats was significantly decreased compared with 4.25% icodextrin-based PDF-injected rats. # P < 0.05 versus C1, † P < 0.05 versus C2, ‡ P < 0.05 versus G. C1, control; C2, diabetic rats with 5/6 kidney ablation; G, diabetic rats with 5/6 kidney ablation injected 4.25% glucose-based PDF; I, diabetic rats with 5/6 kidney ablation injected 7.5% icodextrin-based PDF. Each column consists of mean ± s.e. VWF, von Willebrand factor; VEGF, vascular endothelial growth factor; bFGF, basic fibroblast growth factor; AGE, advanced glycation end-product; RAGE, receptor for AGE. C1, control; C2, diabetic rats with 5/6 kidney ablation; G, diabetic rats with 5/6 kidney ablation injected 4.25% glucose-based peritoneal dialysis fluid (PDF); I, diabetic rats with 5/6 kidney ablation injected 7.5% icodextrin -based PDF. All values are mean ± s.e. n = 8 in each group. The number of positive cells was counted in 10 fields and represented as per mm 2 . a P < 0.05 versus C1 group. b P < 0.05 versus C2 group. c P < 0.05 versus G group.
cell layer and in the blood vessel wall (Figure 4c ). VEGF immunostaining was not different between the other three groups (Figure 4a, b and d) .
To examine the peritoneal fibrosis, we next examined the accumulation of the fibronectin. Marked accumulation of fibronectin in the submesothelial zone was observed in 4.25% glucose-based PDF-injected group as compared to the other three groups (Figure 5a-d) . In addition, the degree of fibronectin accumulation in STZ-induced diabetic rats with 5/6 kidney ablation was significantly increased as compared to the non-treated control group (Figure 5a-d) . We also examined the expression of basic fibroblast growth factor (bFGF) in the peritoneum associated with peritoneal fibrosis. bFGF expression was more pronounced in rats exposed to 4.25% glucose-based PDF, most distinctly in the submesothelial fibrotic tissue and blood vessel walls, compared to other three groups (Figure 6a-d) . No difference in bFGF expression was found between the 7.5% icodextrinbased PDF-injected group and other two control groups (Figure 6a, b and d) .
AGE heavily accumulated in peritoneal tissue exposed to 4.25% glucose-based PDF, which was most obvious in the mesothelial layer and the area of neoangiogenesis (Figure 7c ). AGE accumulation was more pronounced in the 7.5% icodextrin-based PDF-injected group than in the two control groups (Figure 7a, b and d) , but the most prominent 4 . Vascular endothelial growth factor (VEGF) expression was evaluated by a VEGF immunostaining of the peritoneum for the (a) control group, (b) diabetic rats with 5/6 kidney ablation, (c) diabetic rats with 5/6 kidney ablation injected standard 4.25% glucose-based peritoneal dialysis fluid (PDF) for 8 weeks (n = 8), (d) diabetic rats with 5/6 kidney ablation injected 7.5% icodextrin-based PDF for 8 weeks (n = 8). # P < 0.05 versus C1, † P < 0.05 versus C2, ‡ P < 0.05 versus G. accumulation was observed in rats injected with 4.25% glucose-based PDF (Figure 7c ). RAGE expression was higher in the 4.25% glucose-based PDF-injected group than in other experimental groups, which was localized in the mesothelial layer, submesothelial fibrotic tissue and blood vessel walls (Figure 8c) . No difference in RAGE expression was found between the two control groups and 7.5% icodextrin-based PDF-injected group (Figure 8a, b and d ).
Discussion
In this study, chronic exposure of the rat peritoneal membrane to a high-glucose standard PDF resulted in mesothelial damage, development of submesothelial and interstitial fibrosis and pronounced neoangiogenesis. These structural characteristics of the peritoneal membrane are similar of those found in patients on long-term peritoneal dialysis [11] . The salient observation of the present study is that the diverse structural alterations such as fibrosis and angiogenesis were significantly ameliorated with icodextrin-based PDF in STZ induced-diabetic and a uraemic rat model, possibly linked to the reduction of the AGE-RAGE interaction.
There are several reports of in vitro studies assessing the biocompatibility of icodextrin. Ha et al. showed less production of VEGF and procollagen III N-terminal peptide secretion by mesothelial cells during icodextrin, pointing out the enhanced biocompatibility of icodextrin [14] . Formation of amadori albumin, GDP and AGE was reduced during icodextrin in several studies [6, 7] . Bajo et al. showed greater ex vivo proliferation of mesothelial cells taken from icodextrin effluent than from glucose effluent [10] . However, some studies have shown equal cell culture cytotoxicity with icodextrin as with conventional glucose-based solutions [7, 15, 16] . On the other hand, Parikova et al. found more signs of subclinical inflammation during the use of icodextrin than during the use of glucose based-solutions [17] . Furthermore, Gotloib et al. found mesothelial dysplastic changes and lipid peroxidation induced by icodextrin [18] . Thus, there has been a debate over the years why icodextrin is biocompatible for the peritoneal membrane. In its favour, it is iso-osmotic, relatively low in glucose degradation products and perhaps, most important of all, glucose free.
The most important factor responsible for peritoneal deteriorations in PD seems to be GDPs, which stimulate the production of components of the extracellular matrix as well as the synthesis of growth factors, including transforming growth factor beta (TGF-β) and VEGF, through the formation of AGEs [19] . Indeed, carboxymethllysine formed from GDPs, localized to the mesothelial layer and vascular walls of the peritoneal membrane in patients undergoing PD treatment [20] . There is evidence from several studies for a decreased rate of formation of glycated and AGE-modified protein in vitro with icodextrin-versus glucose-based PD solutions [7, [21] [22] [23] . On the basis these previous findings, while we did not demonstrated the direct effect of GDPs on rat peritoneal membrane, usage of icodextrin eliminated direct toxicity of GDP content, resulting in reduction of peritoneal damage.
Mesothelial toxicity is attributable not only directly to GDPs but also as a result of local AGE formation [24] . Carbonyl stress and resulting AGE accumulation contribute to the damage of peritoneal membranes in PD [4] . In addition to the altering effect of AGE on peritoneal integrity due to the cross-reaction with matrix molecules, such as collagen, multiple receptor-dependent damaging pathways have been identified. The interaction of AGE with RAGE, a wellcharacterized receptor for AGE [25] , has been identified as a major cause of peritoneal damage in diabetic [3] and uraemic rats [26] . The AGE-RAGE interaction activates key signal transcription of mediators for inflammation [27] , angiogenesis [28] and fibrosis [3, 27] . Indeed, Lee et al. has reported that diabetic rats, however, were not uraemic; dialysis with icodextrin had significantly lowered peritoneal AGE staining in comparison to rats dialysed with glucose, underscoring the potential of icodextrin for minimizing AGE-mediated membrane alterations [29] . Interestingly, the present study demonstrated that not only AGE accumulation but also RAGE expression in the STZ-induced diabetic and uraemic rat peritoneal membrane was decreased in icodextrin-based PDF as compared to high-glucose-based PDF. Replacing glucose with icodextrin may eliminate direct toxicity of GDP content and AGE formation, resulting in reduction of peritoneal damage such as angiogenesis and fibrosis through the AGE-RAGE interaction.
There is growing concern that long-term chronic exposure to high levels of glucose has serious adverse metabolic effects on peritoneal tissues. It has been noted that tissues from long-term PD patients bear pathologic alterations strikingly similar to diabetic forms vascular disease, with a thickening of the basement membrane, vascular alterations and AGE deposition [30, 31] . High glucose directly affect up-regulation of TGF-β [32] , fibronectin [33] , bFGF [34] and VEGF [35] expression in mesothelial cells, suggesting a relationship between high-glucose exposure and the development of peritoneal fibrosis, extracellular matrix expansion and increased angiogenesis. On the other hand, exposure of the membrane components to high glucose also can have an indirect effect on membrane structure, through AGE formation leading to subsequent alteration in the mesothelial, interstitial and endothelial layers of the membrane [36, 37] . Indeed, the present study clearly showed that the glucose concentrations in dialysis fluid were significantly lower in 7.5% icodextrin-based PDF than in 4.25% glucose-based PDF during an 8-hour dwell, which confirms the previous observation in a normal rat model during 4 h of the dwell [38] . Thus, icodextrin reduces the level of peritoneal membrane glucose exposure, resulting in the potential to significantly minimize many of the directly or indirectly glucose-related cytotoxicities, and therefore reducing peritoneal damage.
During PD, the peritoneum is exposed to high concentrations of GDP derived from not only glucose-based PDF but also from uraemia or diabetes, resulting in an accumulation of AGE within the peritoneal membrane. In fact, uraemia independently induced permeability and structural changes in the rat peritoneum, in parallel with AGE deposits and up-regulation of nitric oxide synthase (NOS) and growth factors [39] . Similar to uraemia, chronic hyperglycaemia itself was associated with functional and structural changes in the rat peritoneum in parallel to the selective regulation of NOS and AGE deposits [40] . In this study, there are no significant differences in plasma glucose and serum creatinine levels between icodextrin and high-glucose-based PDF, suggesting that high glucose and uraemia did not play a pivotal role in the difference of the peritoneal injury. Additionally, in uraemic and diabetic rats without injection of PDF, the peritoneum changes such as peritoneal thickening and fibrosis were significantly pronounced compared to non-treated control rats, suggesting an additional adverse effect of uraemia and diabetes on the development of peritoneal damage. These results are in good agreement with previous reports [39, 40] and contribute to our understanding about the contribution of diabetes and uraemia to the peritoneal injury in vivo.
Since 4.25% glucose-based PDF is one of the most bioincompatible fluids, highly hypertonic with large amounts of glucose and GDPs, 2.25% glucose-based PDF should have been taken part in the control. There were some reasons why we selected 4.25% glucose-based PDF as control. First, 4.25% glucose-based PDF has the highest ultrafiltration performance among glucose-based PDFs and closest to that of 7.5% icodextrin PDF. Second, we focused on peritoneal damage in response to high glucose and GDPs rather than osmolality. Although the osmolality of 4.25% glucosebased PDF is higher than that of 7.5% icodextrin, previous reports suggested that the effect of osmolality was relatively smaller than that of glucose itself in vitro studies [41, 42] . In addition, using 4.25% glucose-based PDF may be helpful to elucidate the effect of high glucose on peritoneal membrane more clearly. Finally, we used Dianeal but not Physioneal as control for a comparison under identical pH and buffer systems. Although a lactate/bicarbonate-buffered alternative is undergoing clinical trials, 7.5% icodextrin PDF is currently buffered with lactate alone. Several studies of new neutral-pH solutions revealed less-severe morphological abnormalities and functional changes of the peritoneal membrane than conventional solutions in a non-diabetic rat model without nephrectomy [43, 44] . Further investigation, in which isotonic (1.5%) and hypertonic (2.5%) Physioneal are compared to 7.5% icodextrin or Dianeal in this similar diabetic rat model with partial nephrectomy, may provide a new therapeutic approach in diabetic PD patients.
The number of newly formed blood vessels and fibrosis in the peritoneum tend to be higher in the rat exposed to icodextrin-based PDF compared with non-injected rats, suggesting that using icodextrin could not completely prevent rat peritoneal injury in vivo. There are several reasons for this result. First, low pH and lactate content are not corrected in icodextrin-based PDF. Second, an increased glucose concentration in rat peritoneum may induce the peritoneal fibrosis or induction of vasculature. The metabolism of icodextrin by rats is known to be much more rapid compared with PD patients because of higher enzyme activity in plasma and peritoneum in rats than in humans [45] . Therefore, icodextrin is metabolized by maltase and amylase in the peritoneum, by which the glucose concentrations in the peritoneum may be increased. Indeed, our result showed that the dialysate glucose concentrations in the 7.5% icodextrin-based PDF group significantly increased at 4 and 8 h compared to 0 h. Nevertheless, the dialysate glucose concentrations at 4 h in the current study were approximately 2-to 3-fold of those in the previous study [38] , which might be explained by a difference in experimental model, i.e. diabetic versus non-diabetic rats. Finally, the subclinical inflammatory response in the peritoneum, which however remains to be elucidated, could be induced by icodextrin. Further studies need to clarify these issues further and elucidate whether the use of icodextrin has drawbacks.
In conclusion, we demonstrated that 8 weeks exposure of the diabetic and uraemic rat peritoneal membrane to icodextrin resulted in less morphological and immunological changes compared to glucose-based PDF. A weakness of this study is the use of the rat for investigating the peritoneal membrane, because rats degrade icodextrin to its metabolites much faster than humans. However, we demonstrated that the dialysate glucose determinations in 7.5% icodextrin-based PDF were significantly lower than in 4.25% glucose-based PDF during an 8-h dwell. Thus, current animal experiments support the notion that icodextrinbased PDF is expected to be useful for preventing the development of peritoneal damage in diabetic PD patients who need higher sustained ultrafiltration, although further clinical studies are required.
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